Skip to content

Clinical research and extension of cognitive impairment rehabilitation and Neuromodulation treatment

Clinical research and extension of cognitive impairment rehabilitation and Neuromodulation treatment

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025045
Enrollment
Unknown
Registered
2019-08-09
Start date
2019-08-15
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Group 3:Transcranial magnetic stimulation
Group 4:Sham Transcranial magnetic stimulation
Group 5:Multi-target transcranial magnetic stimulation
Group 6:Electromagnetic combined stimulation
Group 7:Multi-target transcranial magnetic stimulation with intelligent rehabilitation
Group 8:Electromagnetic combined stimulation with intelligent rehabilitation

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 50-75 years; 2. It meets the diagnostic criteria for AD set by the National institute on aging -AD institute (NIA-AA) in 2011; 3. MMSE<=23?; 4. CDR:1-2; 5. HAMD<17; 6. Hachinski<4; 7. According to the Edinburgh bias test, all are right-handed; 8. Long-term follow-up was agreed and accompanied by qualified informed persons at each follow-up.

Exclusion criteria

Exclusion criteria: 1. Complicated with other neurological diseases and serious diseases of heart, liver, lung and kidney; 2. There are metallic foreign body in the body, such as pacemaker, DBS treatment device, bracket; 3. Those who take benzodiazepines or have a history of drug abuse; 4. Patients with MDD and other severe mental illness.

Design outcomes

Primary

MeasureTime frame
Neuropsychological scale;

Secondary

MeasureTime frame
FMRI;TMS-EEG;

Countries

China

Contacts

Public ContactWang yuping

Xuanwu Hospital Capital Medical University

wangyuping01@sina.cn+86 010-83198273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026